These findings suggest that miR-144-5p exerts anti-obesity effects by enhancing fatty acid oxidation, likely through modulation of the PGC-1α/AMPK signaling pathway. The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.